We found significantly elevated levels of CD19+CD24hiCD38hi Bregs in HIV+ pre-NHL (cART-naïve) compared to HIV+ cART-naïve samples (Figure 6B). This evidence concerns the gene CD19 and non-Hodgkin lymphoma.